Bio-Rad Laboratories, Inc.
NYSE: BIO-B0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz
- Employees
- 7,700
- Headquarters
- Hercules, United States
- IPO year
- 1999
- Market cap
- $7.4B
- Website
- https://www.bio-rad.com
Loading BIO-B…
Loading profile data…Frequently asked questions about BIO-B
What does Bio-Rad Laboratories, Inc. (BIO-B) do?
Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnost...
Where does BIO-B trade?
Bio-Rad Laboratories, Inc. (BIO-B) trades on the New York Stock Exchange.
What sector is BIO-B in?
Bio-Rad Laboratories, Inc. (BIO-B) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bio-Rad Laboratories, Inc.?
Norman D. Schwartz is the chief executive officer of Bio-Rad Laboratories, Inc. (BIO-B).
Where is Bio-Rad Laboratories, Inc. headquartered?
Bio-Rad Laboratories, Inc. is headquartered in United States.
Does BIO-B pay a dividend?
Bio-Rad Laboratories, Inc. (BIO-B) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIO-B go public?
Bio-Rad Laboratories, Inc. (BIO-B) completed its initial public offering in 1999.